ESC 365 - Detection and prevention: what is the role of NOACs in subclinical AF?

Open Access

Detection and prevention: what is the role of NOACs in subclinical AF?

Session: Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF

Topic: Atrial fibrillation (AF)

Speaker: Doctor A. Alings (Utrecht, NL)

Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Antonio Marco Willem Alings

University Medical Center Utrecht, Utrecht (Netherlands (The))

3 presentations

0 follower

4 more presentations in this session

Improving patient care with NOACs: where are we now?

Speaker: Professor H. Heidbuchel (Antwerp, BE)

How can NOACs advance care of AF patients undergoing cardioversion?

Speaker: Professor P. Kirchhof (Hamburg, DE)

NOACs and pulmonary vein ablation: evidence and optimal management.

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Panel discussion - Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF.

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Access the full session

Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF

Speakers: Doctor A. Alings, Professor H. Heidbuchel, Professor P. Kirchhof, Professor H. Heidbuchel, Professor H. Heidbuchel

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Related content

Open Access

Expanding therapeutic options for lowering LDL-c: Where will bempedoic acid and inclisiran contribute.

27 August 2021

Open Access

Key point in tricuspid Valve Imaging.

27 August 2021

ESC Premium Access

How to grade severity of tricuspid regurgitation.

27 August 2021

ESC 365 is supported by